Center for Childhood Cancer Research
CCCR Newsletter
Facebook
Twitter
Ways to Give
Search...
Home
About
Colket Translational Research Building
Abramson Cancer Center
Research Programs & Laboratories
Ways To Give
Donate Now
Research
Hematopoietic Malignancies
Brain Tumors
Neuroblastoma
Sarcoma
Survivorship
Behavioral Oncology
Developmental Therapeutics
Our Team
Leadership
Faculty
Research Administration
Training
Biomedical Graduate Groups
Clinical Fellowships
Cancer Center T32
Cancer Center K12
Clinical Trials
Protocol Search
News & Events
CCCR Newsletter
View Funding Opportunities
CCCR Publications from July 1st 2010 to June 30th 2011
CCCR-ALSF Symposium on Translational Oncology
Contact Us
Faculty
Research Administration
Skip to content
Home
Research
Sarcoma
Naomi Balamuth, MD
Naomi Balamuth, MD
Sarcoma
A phase 1 trial and pharmacokinetic study of cediranib, an orally bioavailable pan-vascular endothelial growth factor receptor inhibitor, in children and adolescents with refractory solid tumors
Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group
Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group
Ewing tumors that do not overexpress BMI-1 are a distinct molecular subclass with variant biology: a report from the Children's Oncology Group
Ewing's sarcoma
Fibula free flap reconstruction of the pelvis in children after limb-sparing internal hemipelvectomy for bone sarcoma
Genitourinary rhabdomyosarcoma: which treatment, how much, and when?
Pharmacokinetically guided phase 1 trial of the IGF-1 receptor antagonist RG1507 in children with recurrent or refractory solid tumors
Phase I trial and pharmacokinetic study of ixabepilone administered daily for 5 days in children and adolescents with refractory solid tumors
Randomized trial and pharmacokinetic study of pegfilgrastim versus filgrastim after dose-intensive chemotherapy in young adults and children with sarcomas
